QDEL
$219.38
Quidel Cp
$4.38
2.04%
QDEL
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $4.04
Revenue:  $363.11 Mil
Thursday
Oct 29
4:10 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, July 30, 2020

What do you expect when QDEL reports earnings?
Beat
Meet
Miss

Where is QDEL's stock price going from here?
Up
Flat
Down
Stock chart of QDEL
Analysts
Summary of analysts' recommendations for QDEL
Score
Grade
Pivots
Resistance
$232.51
$226.73
$223.05

$217.27

Support
$213.59
$207.81
$204.13
Tweet
Growth
Description
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Peers
Myriad GeneticsImmunomedicsCareDxMeridian BioscienceSurModics